Oligomers and oligomer conjugates

MA39996AUndetermined Publication Date: 2015-11-19F HOFFMANN LA ROCHE & CO AG +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA39996
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-05-15
Filing Date: 2015-05-12
Publication Date: 2015-11-19

Application Information

Patent Timeline

15 May 2014

Priority

12 May 2015

Application

MA39996

19 Nov 2015

Publication

MA39996A

IPC: C12N15/113

CPC: A61K31/713; C12N15/1131; C12N2310/11; C12N2310/351; C12N2310/3515; A61K47/549; A61K47/554; A61P1/16

Inventors: JAVANBAKHT Hassan; LINDOW Morten

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to an oligomer conjugate for use in the treatment of a viral disorder. The oligomer conjugate comprises: a) an oligomer capable of modulating a target sequence in hbx and / or hbsag of hepatitis b virus (hbv) to treat said viral disorder; and b) a carrier component capable of delivering the oligomer to the liver which is linked, preferably conjugated, to the oligomer.

Need to check novelty before this filing date? Find Prior Art